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cardiovascular non-stent PMAs approved during that time with a study with at least
one primary endpoint, 16 (24%) had a study modification or primary endpoint
reinterpretation. In one stent PMA, a study did not meet at least one pre-specified
primary endpoint, but the device was approved on the basis of a post-hoc data review.
In another stent PMA, pre-specified statistical analyses were changed after study
initiation.
Conclusion: The most rigorous FDA review process for devices includes numerous
forms of study modifications and primary endpoint reinterpretations, but these occur
less frequently for coronary and non-coronary stent studies. As these types of analyses
reduce confidence in conclusions, more consistent requirements for pre-specified
clinical trial outcomes will help improve the quality and consistency of the approval
process.
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Background: Coronary artery disease (CAD) is the most common cause for left
ventricular dysfunction (LVD). Coronary artery bypass surgery (CABG) results in
equivalent benefit in reducing mortality compared with medical therapy in patients
with CAD and severe LVD. However, the benefit of percutaneous coronary
intervention (PCI) in patients with severe LVD is not clear. A meta-analysis of studies
utilising PCI in patients with severe LVD (EF≤40%) was performed to determine in-
hospital (IH) and long-term (LT) [≥1year] mortality.
Methods: A systematic computerised literature search was performed. Studies of
patients undergoing PCI for CAD in the presence of severe LVD were included. Studies
that did not report LT mortality and same centre studies were excluded.
Results: In total, 4766 patients (19 studies) were included. The mean (pooled estimate)
age was 64.7 years with a mean (estimate) EF of 29.9% and 79.7% were men. The IH
mortality rate using random effects model (13 studies, total PCI n=2202, 39 deaths)
was 1.8% (95% CI 1.0-2.9%). The LT mortality rate (23.86 months) using random
effects model (19 studies, total follow-up n=2937, 401 deaths) was 15.6% (95% CI
11.0-20.7%). Five studies compared PCI versus CABG (n=455 vs. n=502) and provide
LT mortality data (PCI n=102 vs. CABG n=115 deaths). The relative risk using random
effects model (PCI vs. CABG) was 0.98 (95% CI 0.78-1.22, p value 0.83).
Long-term Mortality Following PCI in Severe LV Dysfunction: A Meta-analysis
Conclusion: This meta-analysis demonstrates that based on available clinical studies,
PCI among patients with severe LVD is feasible with acceptable in-hospital and long-
term mortality and yields comparable outcomes with CABG.
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Background: Late catch-up phenomenon in target lesion revascularization (TLR) is
one of the problems after sirolimus-eluting stent (SES) implantation. However, the
way to reduce late TLR after SES implantation has not been established.
Methods: Among 13087 patients undergoing first percutaneous coronary intervention
in the CREDO-Kyoto registry Cohort-2 from January 2005 to December 2007, 10221
patients were implanted only SES (SES stratum: 5029) or only bare-metal stent (BMS)
(BMS stratum: 5192). To evaluate the impact of statin therapy on late TLR (1-year to
4-year), SES implanted patients were divided into 2 groups according to the statin
therapy at discharge (statin group: 2735, non-statin group: 2294). BMS implanted
patients were also divided into 2576 statin and 2616 non-statin group.
Results: Incidence of late TLR was significantly higher in SES implanted patients
compared to BMS implanted patients (7.7% vs. 3.0%, P<0.0001). In SES stratum,
incidence of late TLR was significantly lower in the statin group than in the non-statin
group (6.1% vs. 9.6%, P=0.002), although no significant difference was found in BMS
stratum (2.6% vs. 3.3%, P=0.38). After adjusting confounders, the risk for late TLR
was significantly lower in the statin group in SES stratum (hazard ratio (HR) 0.66 [95%
confidence interval (CI) 0.50-0.88], P=0.004), although the risk was comparable in
BMS stratum (HR 0.83 [95% CI 0.52-1.31], P=0.42).
Conclusion: Incidence of late TLR was significantly higher in SES than in BMS
implanted patients. Statin therapy significantly reduced late TRL after SES
implantation, although significant risk reduction was not found after BMS
implantation.
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Background: Socioeconomic factors such as insurance and household income impact
cardiovascular risk and outcomes, but the influence of marital status upon outcomes
following PCI is poorly understood.
Methods: We compared 2971 currently married patients to 2213 unmarried patients,
defined as single, widowed, divorced or separated, at one year following PCI. Patients
were followed for 1 year in regards to the combined endpoint of all-cause death and
MI; the latter was defined as CK-MB elevation ≥2 times upper limit of normal and/or
new Q waves or ST elevation ≥1 mm. Multivariable Cox proportional hazards
regression was performed to adjust for confounders.
Results: Married patients, compared to unmarried patients, were more likely to be
male (76.3% v. 53.6%) or Caucasian (77.0% v. 59.4%) and were less likely to present
with acute coronary syndrome (10.1% v. 16.5%) or have congestive heart failure
(11.1% v. 15.8%) or chronic renal insufficiency (8.8% vs. 14.2%; p<0.001 for all
comparisons). Unadjusted 1-year death (3.2% v. 7.4%, p<0.001) and death plus MI
(4.3% v. 9.6%, p<0.001) were lower among married patients compared to married
patients, as was definite and probable stent thrombosis (0.4% v. 1.2%, p=0.002).
Following multivariable adjustment, being married remained associated with lower
rates of death and MI at 1 year (HR 1.63, 95% CI 1.29-2.07, p<0.001; Table).
Conclusion: The presence of social support, possibly by ensuring better medication
compliance, lifestyle modification and follow-up, improves outcomes following PCI.
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Background: Pressure-controlled intermittent coronary sinus occlusion (PICSO®)
may serve as an adjuvant therapy in acute myocardial infarction by augmenting
redistribution of blood to the border zone of the ischemic myocardium. This first-in-
man study evaluated safety and feasibility of PICSO®, and its effect on coronary
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